Neuronetics Inc at JMP Securities Life Sciences Conference Transcript

May 16, 2023 / 04:30PM GMT
Daniel Stauder - JMP Securities LLC - Analyst

Welcome to day two of the JMP Life Sciences Conference. I'm pleased to introduce members of Neuronetics management team. We have CEO, Keith Sullivan; CFO, Steve Furlong. Before we get into it, just as a reminder, Neuronetics is a leader in the TMS space, treating a range of neurological disorders, primarily major depressive disorder.

Questions and Answers:

Daniel Stauder - JMP Securities LLC - Analyst

So just with that, let's get going. Keith, you've been at the helm for almost three years now. We would love to hear your high-level perspective on where the TMS market stands right now, what has changed in the industry since you've joined, and where Neuronetics stands within that today.

Keith Sullivan - Neuronetics, Inc. - President & CEO

Very good. Well, thanks for having us.

Daniel Stauder - JMP Securities LLC - Analyst

Of course. Thank you for coming.

Keith Sullivan - Neuronetics, Inc. -
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot